FWA
ABBV icon

FSC Wealth Advisors’s AbbVie ABBV Stock Holding History

FSC Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,431
Closed -$555K – 14
2025
Q4 		$555K Hold
2,431
– – 0.9% 21
2025
Q3 		$563K Buy
2,431
+5
+0.2% +$1.02K 0.32% 41
2025
Q2 		$450K Sell
2,426
-107
-4% -$19.9K 0.28% 45
2025
Q1 		$531K Buy
2,533
+1
+0% +$194 0.35% 41
2024
Q4 		$450K Sell
2,532
-5
-0.2% -$919 0.29% 47
2024
Q3 		$501K Buy
2,537
+91
+4% +$17K 0.36% 45
2024
Q2 		$419K Buy
2,446
+321
+15% +$53.2K 0.31% 41
2024
Q1 		$387K Sell
2,125
-80
-4% -$13.8K 0.27% 39
2023
Q4 		$342K Buy
2,205
+34
+2% +$4.96K 0.25% 39
2023
Q3 		$324K Buy
2,171
+110
+5% +$16.1K 0.34% 23
2023
Q2 		$278K Hold
2,061
– – 0.25% 24
2023
Q1 		$328K Buy
2,061
+232
+13% +$35.5K 0.52% 13
2022
Q4 		$296K Hold
1,829
– – 0.51% 15
2022
Q3 		$245K Buy
1,829
+713
+64% +$102K 2.36% 10
2022
Q2 		$171K Hold
1,116
– – 1.52% 16
2022
Q1 		$181K Hold
1,116
– – 0.17% 25
2021
Q4 		$151K Buy
+1,116
New +$132K 0.1% 41

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FSC Wealth Advisors's ABBV Position: Q1 2026 in Review

FSC Wealth Advisors sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 2,431 shares — an estimated $555K sold.

FSC Wealth Advisors first reported a position in ABBV in Q4 2021 and held it in 17 quarters. The position peaked at $563K in Q3 2025. 4,097 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • FSC Wealth Advisors reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
  • FSC Wealth Advisors sold 2,431 AbbVie shares in Q1 2026, an estimated $555K.
  • FSC Wealth Advisors first reported a position in AbbVie in Q4 2021 and held it in 17 quarters.
  • FSC Wealth Advisors's AbbVie position peaked at $563K in Q3 2025.
  • 4,097 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on FSC Wealth Advisors's 13F filing for Q1 2026, filed 20 Apr 2026.